|
Founded in 1993, Shaanxi Wan' an Pharmaceutical is a modern pharmaceutical enterprise incorporating with science research, production and sales. With a fixed assets of about RMB 65 million Yuan (About 8 million USD) and an annual sales volume of over RMB 50 million Yuan (About 6 million USD), Wan' an Pharmaceutical has 500 employees currently, 50% of which are medical professionals, including a scientific research group consisting of 5 medical ***tors and 11 masters, an expert group consisting of more than 70 gynecological ***tors.
Zimeishu gynecological pad has a prominent effect on curing and prevention of gynecopathy. It has passed ISO9001: 2000 the international quality standard and ISO13485: 1996 the international medical equipment standard. At present, the sales network has stretched to large- and medium-sized cities all over the country, and has won favors of both individual and groups, a population over 6 million. The product Zimeishu has unique advantages. Its intangible value has reached RMB 0.3 billion Yuan (About 37 million USD) as evaluated. In 2004, the brand was granted the honor of " China Industrial Leading Brand" on " China First- session Brand Competition". At present, the brand Zimeishu has been registered and was protected in several countries. It has exported to countries (regions) as Europe, America, Southeast Asia and Middle East.
In order to improve the life quality of women, and accelerate the development of the nation, the staffs of Wan' an, adhering to the conception of "Working with credibility and seeking for perfection", setting up the tenet of "Making efforts for the health of millions of women and the prosperity of China", taking "Zimeishu" as the carrier of their deep passion, will surely make their own contribution to the physical and psychological health of women.
|
Company: |
Shaanxi Wanan Pharmaceutical Co ., Ltd
|
Contact: |
Ms. Huang Emily |
Address: |
F23, CITIC Mansion, No89,North Changan Road, |
Postcode: |
710061 |
Tel: |
86 29 87819001ext8045 |
Fax: |
86 29 87803213 |
E-mail: |
|
|
|
|